Download PDF
Malnutrition in cancer patients leads to poorer health outcomes. It also results in an increased burden to healthcare resources. Nutritional care should be an integral part of cancer care.
Cancer biomarkers are molecules that can be detected in bodily fluids or tissues. Cancer biomarkers can identify people who have cancer or who are at risk of getting cancer.
A new study shows the costs of ‘doing nothing’: the inactivity time bomb is killing 500,000 Europeans, and costing over € 80 billion per year. ISCA (International Sport & Culture Association) is campaignin to get 100 million Europeans to move more by 2020. Read the full report and find out what you can do to help get Europe moving at http://inactivity-time-bomb.nowwemove.com.
Cancer is the second most common cause of death in the European Union. New approaches are urgently needed to address the growing number of cancer cases diagnosed each year.
56 million in Europe have diabetes. By 2035, this number is expected to grow to nearly 70 million, underlining shortcomings of existing policies to fight the disease.
